Remedium Lifecare Q2 Results
- BSE: 539561
- NSE: -
- ISIN: INE549S01036
- Sector: Biotechnology & Drugs
BSE
5.84
-0.11 (-1.85%)
-0.11 (-1.85%)Volume1.93 L
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹25.08 Cr.(-67.72%)
- Operating Profit₹4.45 Cr.(96.28%)
- Profit After Tax₹1.77 Cr.(8.50%)
- Operating Margin17.74%(698.74%)
Note: Comparison is on YoY basis
Quarterly - Remedium Lifecare Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 25.08 | 330.46 | -% | 468.57 | -% |
| Selling/ General/ Admin Expenses Total | 0.24 | 0.28 | -% | 0.21 | -% |
| Depreciation/ Amortization | 0.01 | 0.01 | -% | 0.01 | -% |
| Other Operating Expenses Total | 1.43 | 0.89 | -% | -1.76 | -% |
| Total Operating Expense | 20.63 | 323.20 | -% | 458.16 | -% |
| Operating Income | 4.45 | 7.27 | -% | 10.40 | -% |
| Net Income Before Taxes | 2.46 | 7.27 | -% | 10.40 | -% |
| Net Income | 1.77 | 5.25 | -% | 6.53 | -% |
| Diluted Normalized EPS | 0.04 | 0.52 | -% | 0.65 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
02C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read06:59 PM IST - Markets
03Stocks to buy or sell: Dharmesh Shah of ICICI Securities recommends buying L&T, Syngene International on November 25
5 min read10:00 AM IST